The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Impaired glucose tolerance in patients with amyotrophic lateral sclerosis
Abstract
Our objectives were to analyse carbohydrate metabolism in a series of ALS patients and to examine potential association with parameters of lipid metabolism and clinical features. Glucose tolerance was assessed by the oral glucose tolerance test in 21 non-diabetic ALS patients and compared with 21 age- and sex-matched normal subjects. Lipids and lactate/pyruvate ratio, levels of pro-inflammatory cytokines (tumour necrosis factor-alpha and interleukin-6) and adipocytokines (leptin and adiponectin) were also measured in ALS patients. Mann-Whitney U-tests analysed continuous data and Fisher's exact tests assessed categorical data. Blood glucose determined 120 min after the glucose bolus was significantly higher in patients with ALS (7.41 mmol/l+/-1.68) compared to controls (6.05+/-1.44, p=0.006). ALS patients with impaired glucose tolerance (IGT) according to WHO criteria (n=7, 33%) were more likely to have elevated free fatty acids (FFA) levels compared to patients with normal glucose tolerance (0.77 nmol/l+/-0.30 vs. 0.57+/-0.19, p=0.04). IGT was not associated with disease duration or severity. In conclusion, patients with ALS show abnormal glucose tolerance that could be associated with increased FFA levels, a key determinant of insulin resistance. The origin of glucose homeostasis abnormalities in ALS may be multifactorial and deserves further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Exercise, Glucose Transport, and Insulin Sensitivity
Goodyear, L. J., & Kahn, B. B. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.235 · Cited by 1,056 · cited 1×
“Similarly, prolonged inactivity can induce insulin resistance (15,16), but we found no association between glucose intolerance and the degree of muscle atrophy or weakness, functional impairment or whether the patient could walk.”
BackgroundInflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., & Horwitz, R. I. (2003) · Neurology · doi:10.1212/01.wnl.0000063318.66140.a3 · Cited by 126
Cited by
Brain metabolism in health, aging, and neurodegeneration
Camandola, S., & Mattson, M. P. (2017) · The EMBO Journal · doi:10.15252/embj.201695810 · Cited by 752
Energy metabolism in amyotrophic lateral sclerosis
Dupuis, L., Pradat, P.-F., Ludolph, A. C., & Loeffler, J.-P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70224-6 · Cited by 537
Self-citationNeuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
Tracey, T. J., Steyn, F. J., Wolvetang, E. J., & Ngo, S. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00010 · Cited by 433
Dorst, J., Kühnlein, P., Hendrich, C., Kassubek, J., Sperfeld, A. D., & Ludolph, A. C. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5805-z · Cited by 263
Energy metabolism in ALS: an underappreciated opportunity?
Vandoorne, T., De Bock, K., & Van Den Bosch, L. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1835-x · Cited by 262
Vercruysse, P., Vieau, D., Blum, D., Petersén, Å., & Dupuis, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00002 · Cited by 172
Self-citationAssociation between diabetes and amyotrophic lateral sclerosis in Sweden
Mariosa, D., Kamel, F., Bellocco, R., Ye, W., & Fang, F. (2015) · European Journal of Neurology · doi:10.1111/ene.12632 · Cited by 120
“Furthermore, a connection between metabolic disorders and ALS is supported by the fact that ALS patients are hypermetabolic and have impaired glucose tolerance [6,7].”
BackgroundShimizu, T., Nagaoka, U., Nakayama, Y., Kawata, A., Kugimoto, C., Kuroiwa, Y., Kawai, M., Shimohata, T., Nishizawa, M., Mihara, B., et al. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2012.678366 · Cited by 111
Systemic metabolism in frontotemporal dementia
Ahmed, R. M., MacMillan, M., Bartley, L., Halliday, G. M., Kiernan, M. C., Hodges, J. R., & Piguet, O. (2014) · Neurology · doi:10.1212/wnl.0000000000000993 · Cited by 70
The role of pre‐morbid diabetes on developing amyotrophic lateral sclerosis
D'Ovidio, F., d'Errico, A., Carnà, P., Calvo, A., Costa, G., & Chiò, A. (2018) · European Journal of Neurology · doi:10.1111/ene.13465 · Cited by 59
Antidiabetics, statins and the risk of amyotrophic lateral sclerosis
Mariosa, D., Kamel, F., Bellocco, R., Ronnevi, L. ‐., Almqvist, C., Larsson, H., Ye, W., & Fang, F. (2020) · European Journal of Neurology · doi:10.1111/ene.14190 · Cited by 38
“The associations of type 1 and type 2 diabetes with ALS are probably different and, despite the protective effect of type 2 diabetes on risk, impaired glucose tolerance is common in patients with ALS [3,4,6].”
BackgroundLipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Godoy-Corchuelo, J. M., Fernández-Beltrán, L. C., Ali, Z., Gil-Moreno, M. J., López-Carbonero, J. I., Guerrero-Sola, A., Larrad-Sainz, A., Matias-Guiu, J., Matias-Guiu, J. A., Cunningham, T. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051105 · Cited by 35
“When using non-omics techniques for the analysis of plasma samples of ALS patients, an increase in total fatty acids is observed, without changes in the TG levels [53,74,75].”
MethodAbnormal energy metabolism in ALS: a key player?
Burg, T., & Van Den Bosch, L. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001164 · Cited by 24
Lipocalin‐2 is increased in amyotrophic lateral sclerosis
Petrozziello, T., Mills, A. N., Farhan, S. M. K., Mueller, K. A., Granucci, E. J., Glajch, K. E., Chan, J., Chew, S., Berry, J. D., & Sadri‐Vakili, G. (2020) · Muscle & Nerve · doi:10.1002/mus.26911 · Cited by 17
Metadata
- Authors
- Pradat, P.-F., Bruneteau, G., Gordon, P. H., Dupuis, L., Bonnefont-Rousselot, D., Simon, D., Salachas, F., Corcia, P., Frochot, V., Lacorte, J.-M., Jardel, C., Coussieu, C., Le Forestier, N., Lacomblez, L., Loeffler, J.-P., & Meininger, V.
- Venue
- Amyotrophic Lateral Sclerosis
- Publisher
- Informa UK Limited
- Published
- 2010-01
- Volume
- 11
- Issue
- 1-2
- Pages
- 166-171
- ISSN
- 1471-180X (ISSN-L)
- 1748-2968
- OpenAlex
- W2072988920
- Cited by
- 176
- References
- 6
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.